AGG vs IBB
iShares Core US Aggregate Bond ETF vs iShares Biotechnology ETF
- • AGG has the lower expense ratio at 0.03% vs 0.44% for IBB.
- • AGG pays a higher dividend yield (3.97%).
Side-by-side metrics
| Metric | AGG | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.44% |
Dividend yield Trailing 12-month yield. | 3.97% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $138.85B | $9.09B |
YTD return | 0.12% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.99 | 0.69 |
P/E ratio | 125.38 | 24.79 |
Last price | $98.30 | $196.62 |
Inception | — | — |
Issuer | iShares | iShares |
AGG top holdings
| BISXX | BlackRock Cash Funds Instl SL Agency | 2.97% |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
About AGG
AGG (iShares Core US Aggregate Bond ETF) is Tracks the Bloomberg US Aggregate Bond Index. Managed by iShares, the fund carries $138.8B in assets under management, an expense ratio of 0.03%, a dividend yield of 3.97%. Its largest holding is BlackRock Cash Funds Instl SL Agency (BISXX), which represents 3.0% of the portfolio.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.